SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-037533
Filing Date
2022-03-24
Accepted
2022-03-24 16:42:44
Documents
14
Period of Report
2022-03-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2210238d1_8k.htm   iXBRL 8-K 28126
2 EXHIBIT 99.1 tm2210238d1_ex99-1.htm EX-99.1 219519
6 GRAPHIC tm2210238d1_ex99-1img001.jpg GRAPHIC 2862
  Complete submission text file 0001104659-22-037533.txt   445425

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA enfn-20220324.xsd EX-101.SCH 3033
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE enfn-20220324_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enfn-20220324_pre.xml EX-101.PRE 22595
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2210238d1_8k_htm.xml XML 3730
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Filer) CIK: 0001868912 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40949 | Film No.: 22767036
SIC: 7372 Services-Prepackaged Software